Lean Everywhere Except Your Belly? The Tesamorelin Solution for Visceral Fat

You've done the work. Lost 15 kilos. Your arms look great, your legs are lean, and your face is noticeably thinner. But when you look down at your midsection, it's like the fat loss memo never arrived. Your belly looks almost identical to how it looked 15 kilos ago - still protruding, still soft, still the first thing you see in the mirror.

You've tried everything specifically for your belly. Endless crunches that did nothing. Planks until your core burns. Cut carbs, tried intermittent fasting, added more cardio. The scale keeps dropping, your clothes fit better everywhere else, but your midsection remains frustratingly unchanged.

Here's what nobody's telling you: your stubborn belly fat isn't the same as the fat you've successfully lost elsewhere. It's visceral fat—metabolically different, hormonally resistant, and fundamentally more challenging to mobilise than subcutaneous fat. Eliminating it requires a targeted approach that general weight loss methods can't provide.

The Two Types of Fat

When people talk about "belly fat," they're usually referring to two completely different types of fat that happen to occupy the same area. Subcutaneous fat sits just under your skin - it's what you can pinch between your fingers. Visceral fat sits deep in your abdomen, surrounding your organs.

These aren't just different locations—they're biologically distinct fat deposits that respond to distinct hormonal signals and metabolic processes. Subcutaneous fat responds reasonably well to caloric deficits. Visceral fat is far more stubborn and requires specific interventions to mobilise effectively.

When your belly won't flatten despite overall weight loss, you're typically dealing with excess visceral fat that hasn't responded to the same approaches that successfully reduced subcutaneous fat elsewhere.

Why Visceral Fat Is So Stubborn

Visceral fat accumulates for different reasons than subcutaneous fat and defends itself through various mechanisms. It's highly responsive to cortisol and stress hormones, meaning chronic stress directly promotes its accumulation. It's closely linked to insulin resistance, creating a vicious cycle in which visceral fat promotes metabolic dysfunction, which in turn promotes further visceral fat storage.

Unlike relatively inert subcutaneous fat, visceral fat is metabolically active - constantly releasing inflammatory compounds that interfere with normal metabolism. This inflammatory environment makes it increasingly difficult to mobilise whilst simultaneously promoting further accumulation.

Traditional weight loss approaches can reduce visceral fat, but often do so far less effectively than they reduce subcutaneous fat. You end up being lean everywhere except your midsection.

The Health Risk Beyond Aesthetics

Visceral fat isn't just aesthetically frustrating - it's the most dangerous type of body fat from a health perspective. The inflammatory compounds it releases contribute to insulin resistance, cardiovascular disease, and metabolic syndrome.

This is why people with significant belly fat often have worse metabolic markers—elevated blood sugar, poor lipid profiles, and high blood pressure—even if they're relatively lean elsewhere. Visceral fat actively harms metabolic health in ways subcutaneous fat doesn't.

The Growth Hormone Connection

One of the most effective biological signals for visceral fat mobilisation is growth hormone. Unlike many other hormones, growth hormone specifically targets visceral adipose tissue, promoting its breakdown and mobilisation preferentially over subcutaneous fat.

This is why visceral fat accumulation is so closely linked to declining growth hormone levels with age. As growth hormone decreases, visceral fat accumulates. As visceral fat accumulates, it further suppresses growth hormone production, creating a downward spiral.

Breaking this cycle requires restoring the growth hormone signals that specifically target visceral fat for mobilisation.

The Targeted Solution

Tesamorelin is a growth hormone-releasing hormone (GHRH) analogue specifically designed to target visceral abdominal fat. Unlike general fat-loss compounds, it works by stimulating sustained natural growth hormone production, which preferentially mobilises deep belly fat.

This isn't about general weight loss—it's about targeting visceral fat that causes stubborn belly protrusion and metabolic dysfunction. Elevated growth hormone directly signals visceral adipose tissue to break down.

The Mechanism

Tesamorelin binds to GHRH receptors in your pituitary gland, triggering sustained pulses of increased natural growth hormone production. This elevated growth hormone specifically targets visceral adipose tissue, enhancing lipolysis—the breakdown of stored fat into fatty acids that can be burned for energy.

The preferential effect on visceral fat is what makes Tesamorelin unique. Whilst general fat-loss approaches reduce all fat somewhat equally, Tesamorelin's growth hormone stimulation targets explicitly the deep abdominal fat that's been resisting your efforts. This creates visible flattening of the midsection even without significant overall weight loss.

The compound also improves the metabolic dysfunction caused by visceral fat—enhancing insulin sensitivity, improving lipid profiles, and reducing the inflammatory burden.

The Clinical Evidence

Clinical studies demonstrate Tesamorelin's specific efficacy in reducing visceral fat. Research shows average reductions of 15-20% in visceral adipose tissue over 6 months of use—substantial decreases in the exact fat deposit that causes stubborn belly protrusion.

These reductions in visceral fat correlate with significant improvements in metabolic health markers: improved insulin sensitivity, better lipid profiles, and reduced inflammation. Users aren't just losing belly fat—they're reversing the metabolic dysfunction caused by visceral fat.

The Protocol

Tesamorelin is administered via subcutaneous injection at 1-2mg once daily, typically in the abdominal area before bed. Users usually continue for 3-6 months to achieve significant reductions in visceral fat. The effects build progressively as sustained elevation of growth hormone mobilises deep abdominal fat.

The Results Timeline

Users targeting visceral fat typically experience:

Weeks 1-4

Improved sleep quality, energy, and initial metabolic improvements.

Weeks 4-8

Noticeable reduction in abdominal circumference and waist size as visceral fat begins to mobilise.

Weeks 8-16

Substantial flattening of the midsection and a visible reduction in belly protrusion.

Months 4-6

Comprehensive transformation with 15-20% reduction in visceral fat and substantial metabolic health improvements.

Real-World Transformations

Users consistently report that Tesamorelin finally addresses the stubborn belly fat that persisted despite successful overall weight loss. Midsections that remained protruded despite being lean elsewhere finally flattened. Waist sizes drop substantially even without significant overall weight change.

Users report feeling healthier—improved energy, better metabolic markers, reduced inflammation—reflecting the comprehensive benefits of visceral fat reduction beyond aesthetics.

The Targeted Approach

Suppose you've achieved significant weight loss everywhere except your stubborn belly. In that case, the problem isn't that you need to lose more weight overall or do more ab exercises—it's that visceral fat requires targeted intervention through mechanisms that general weight-loss approaches don't adequately address.

Target your stubborn visceral fat with Tesamorelin at Fragment and experience what happens when you specifically address the fat deposit that's been resisting everything else.

Sometimes the solution isn't working harder at what isn't working—it's using a targeted approach designed for the specific type of fat you're dealing with.